Related references
Note: Only part of the references are listed.CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells
Hanan Bloomer et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Nano-assembly of a Chemically Tailored Cas9 Ribonucleoprotein for In Vivo Gene Editing and Cancer Immunotherapy
Juhee Lee et al.
CHEMISTRY OF MATERIALS (2022)
Spatiotemporal multiplexed immunofluorescence imaging of living cells and tissues with bioorthogonal cycling of fluorescent probes
Jina Ko et al.
NATURE BIOTECHNOLOGY (2022)
Enhancing CRISPR/Cas gene editing through modulating cellular mechanical properties for cancer therapy
Di Zhang et al.
NATURE NANOTECHNOLOGY (2022)
Viral vector-based gene therapies in the clinic
Zongmin Zhao et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2022)
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Xin-Zhu Chen et al.
FRONTIERS IN PHARMACOLOGY (2022)
In Vivo Click Chemistry Enables Multiplexed Intravital Microscopy
Jina Ko et al.
ADVANCED SCIENCE (2022)
Recent progress in antibody-drug conjugate therapy for cancer
Sara A. Hurvitz
NATURE CANCER (2022)
Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
Jutaek Nam et al.
ADVANCED SCIENCE (2021)
Cas9 conjugate complex delivering donor DNA for efficient gene editing by homology-directed repair
Yoo Kyung Kang et al.
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY (2021)
Improving the efficiency of CRISPR-Cas12a-based genome editing with site-specific covalent Cas12a-crRNA conjugates
Xinyu Ling et al.
MOLECULAR CELL (2021)
CRISPR-cas9 genome editing delivery systems for targeted cancer therapy
Asma Ghaemi et al.
LIFE SCIENCES (2021)
Protocol for assessment of the efficiency of CRISPR/Cas RNP delivery to different types of target cells
Marina A. Tyumentseva et al.
PLOS ONE (2021)
Bioorthogonal chemistry
Samuel L. Scinto et al.
NATURE REVIEWS METHODS PRIMERS (2021)
Click activated protodrugs against cancer increase the therapeutic potential of chemotherapy through local capture and activation
Kui Wu et al.
CHEMICAL SCIENCE (2021)
Synthetic lethality as an engine for cancer drug target discovery
Alan Huang et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Polymer-stabilized Cas9 nanoparticles and modified repair templates increase genome editing efficiency
David N. Nguyen et al.
NATURE BIOTECHNOLOGY (2020)
Improving the efficiency of precise genome editing with site-specific Cas9-oligonucleotide conjugates
Xinyu Ling et al.
SCIENCE ADVANCES (2020)
Recent advances of thiol-selective bioconjugation reactions
Philipp Ochtrop et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2020)
Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Tuo Wei et al.
NATURE COMMUNICATIONS (2020)
Combinatorial drug therapy in cancer - New insights
Karanpreet Bhatia et al.
LIFE SCIENCES (2020)
Rational design of minimum CRISPR guide RNA by site-specific Cas9-RNA conjugation
Xinyu Ling et al.
CHEMICAL COMMUNICATIONS (2020)
Contemporary approaches to site-selective protein modification
Emily A. Hoyt et al.
NATURE REVIEWS CHEMISTRY (2019)
A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing
Guojun Chen et al.
NATURE NANOTECHNOLOGY (2019)
Multicomponent Reactions in Ligation and Bioconjugation Chemistry
Leslie Reguera et al.
ACCOUNTS OF CHEMICAL RESEARCH (2018)
Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment
Seung Mm Kim et al.
ACS NANO (2018)
Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
Romain Rouet et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
Hong-Xia Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
Katherine Sullivan-Reed et al.
CELL REPORTS (2018)
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Chang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Structural insights into DNA cleavage activation of CRISPR-Cas9 system
Cong Huai et al.
NATURE COMMUNICATIONS (2017)
Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair
Kunwoo Lee et al.
NATURE BIOMEDICAL ENGINEERING (2017)
CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery
Hong-Xia Wang et al.
CHEMICAL REVIEWS (2017)
Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance
Yoo Kyung Kang et al.
BIOCONJUGATE CHEMISTRY (2017)
Site-selective protein-modification chemistry for basic biology and drug development
Nikolaus Krall et al.
NATURE CHEMISTRY (2016)
A chemical biology route to site-specific authentic protein modifications
Aerin Yang et al.
SCIENCE (2016)
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Christopher J. Lord et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Advances in Chemical Protein Modification
Omar Boutureira et al.
CHEMICAL REVIEWS (2015)
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Hiroshi Nishimasu et al.
CELL (2014)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
Suresh Ramakrishna et al.
GENOME RESEARCH (2014)
Advances in using PARP inhibitors to treat cancer
Shivaani Kummar et al.
BMC MEDICINE (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Cu-free click cycloaddition reactions in chemical biology
John C. Jewett et al.
CHEMICAL SOCIETY REVIEWS (2010)
Addition of p-azido-L-phenylaianine to the genetic code of Escherichia coli
JW Chin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
Share Paper
